FDA Looks Ahead to New Biologics Director
The Food and Drug Administration is preparing for a new leader at its Center for Biologics Evaluation and Research. Last month the agency announced that Vinay Prasad, who has worked as an oncologist and was vocal about U. S. drug policies, would step down by the end of April. The decision to replace